Peri-procedural Myocardial Infarction
Also known as: Post procedural myocardial infarction / Periprocedural myocardial infarction
Drug | Drug Name | Drug Description |
---|---|---|
DB06441 | Cangrelor | A P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST). |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06441 | Cangrelor | P2Y purinoceptor 12 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00758 | Clopidogrel | 4 | Completed | 1 |
DB08816 | Ticagrelor | 4 | Completed | 1 |
DB01394 | Colchicine | Not Available | Not Yet Recruiting | 1 |